Why ARTV? Artiva Biotherapeutics, Inc. Analysis, Price & AI Insights | Whystock
ARTV
$10.80+0.56 (+5.47%)
Market ClosedLast close May 1
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.